Serum TSH is not a risk factor for malignancy of pediatric thyroid nodules

in Endocrine-Related Cancer
View More View Less
  • 1 Department of Tumor and Immunology, Beijing Children’s Hospital, Capital Medical University, National Center for Children's Health, Beijing, China
  • 2 Department of Clinical Laboratory Center, Beijing Children’s Hospital, Capital Medical University, Beijing, China
  • 3 Department of Otorhinolaryngology, Head and Neck Surgery, Beijing Children’s Hospital, Capital Medical University, Beijing, China

Correspondence should be addressed to X Ni or W Song: nixin@bch.com.cn or songwenqi1218@163.com

*(G Wang and N Ren contributed equally to this work)

Restricted access

It is uncertain whether serum TSH concentration is an independent risk factor for the malignancy of pediatric thyroid nodules. We sought the association of serum TSH concentration with the malignancy of pediatric thyroid nodules and with the characteristics of pediatric thyroid cancer. A total of 219 pediatric thyroid nodule patients were collected retrospectively for 5 consecutive years. The medical records collected included sex, age, serum TSH concentration, thyroid autoantibody status, thyroid ultra-sonography parameters, histological type, and pathological TNM stages. The serum TSH concentrations were compared between benign and malignant nodules or corresponding subgroups. Binary logistic regression analysis was used to evaluate the correlation of TSH concentration with the malignancy of thyroid nodules and with the characteristics of pediatric thyroid cancer. There was no significant difference in TSH concentration between benign nodule and thyroid cancer in total subjects and various subgroups. The serum TSH level was not correlated with the malignancy of thyroid nodules in univariate analysis, but negatively correlated with the malignancy of thyroid nodules (odds ratio = 0.856, P  = 0.013) after adjusting for the patients’ sex, age, thyroid autoantibody status, and nodule size. The serum TSH level was not correlated with the tumor characteristics in pediatric thyroid cancer patients. In conclusion, the serum TSH concentration seems not to be a carcinogenic factor in pediatric thyroid nodule patients, nor to be an independent risk factor for characteristics of pre-existing pediatric thyroid cancers.

Supplementary Materials

    • Supplementary Table 1 Comparison of the characteristics between the nodules with pathological or cytological evidence and those without in pediatric benign thyroid nodule patients
    • Supplementary Table 2 Univariate logistic regression analyses the correlation of variables with either the TSH concentration or the incidence of thyroid cancer (n = 219)
    • Supplementary Table 3 Multivariate logistic regression analysis the correlation between TSH concentration (in quintiles) and risk for thyroid cancer
    • Supplementary Table 4 Logistic regression analysis the correlation between TSH concentration and risk for thyroid cancer in pathological or cytological confirmed thyroid nodules (n = 114)

 

Society for Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 306 306 306
Full Text Views 12 12 12
PDF Downloads 16 16 16
  • Alderton GK 2012 Tumour immunology: suppressing tumorigenic inflammation. Nature Reviews. Cancer 12 228. (https://doi.org/10.1038/nrc3252)

    • Search Google Scholar
    • Export Citation
  • Arif S, Blanes A & Diaz-Cano SJ 2002 Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma. Histopathology 41 357362. (https://doi.org/10.1046/j.1365-2559.2002.01467.x)

    • Search Google Scholar
    • Export Citation
  • Boelaert K, Horacek J, Holder RL, Watkinson JC, Sheppard MC & Franklyn JA 2006 Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. Journal of Clinical Endocrinology & Metabolism 91 42954301. (https://doi.org/10.1210/jc.2006-0527)

    • Search Google Scholar
    • Export Citation
  • Bohn MK, Higgins V, Asgari S, Leung F, Hoffman B, Macri J & Adeli K 2019 Paediatric reference intervals for 17 Roche cobas 8000 e602 immunoassays in the CALIPER cohort of healthy children and adolescents. Clinical Chemistry & Laboratory Medicine 57 19681979. (https://doi.org/10.1515/cclm-2019-0707)

    • Search Google Scholar
    • Export Citation
  • Boi F, Minerba L, Lai ML, Marziani B, Figus B, Spanu F, Borghero A & Mariotti S 2013 Both thyroid autoimmunity and increased serum TSH are independent risk factors for malignancy in patients with thyroid nodules. Journal of Endocrinological Investigation 36 313320. (https://doi.org/10.3275/8579)

    • Search Google Scholar
    • Export Citation
  • Carayon P, Thomas-Morovan C, Castanas E & Tubiana M 1980 Human thyroid cancer: membrane thyrotropin binding and adenylate cyclase activity. Journal of Clinical Endocrinology & Metabolism 51 915920. (https://doi.org/10.1210/jcem-51-4-915)

    • Search Google Scholar
    • Export Citation
  • Caturegli P, De Remigis A & Rose NR 2014 Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmunity Reviews 13 391397. (https://doi.org/10.1016/j.autrev.2014.01.007)

    • Search Google Scholar
    • Export Citation
  • Chiu HK, Sanda S, Fechner PY & Pihoker C 2012 Correlation of TSH with the risk of paediatric thyroid carcinoma. Clinical Endocrinology 77 316322. (https://doi.org/10.1111/j.1365-2265.2012.04383.x)

    • Search Google Scholar
    • Export Citation
  • Corrias A, Cassio A, Weber G, Mussa A, Wasniewska M, Rapa A, Gastaldi R, Einaudi S, Baronio F & Vigone MC et al. 2008 Thyroid nodules and cancer in children and adolescents affected by autoimmune thyroiditis. Archives of Pediatrics & Adolescent Medicine 162 526531. (https://doi.org/10.1001/archpedi.162.6.526)

    • Search Google Scholar
    • Export Citation
  • Duccini K, de Souza MVL, Delfim R, Aguiar AP, Teixeira P & Vaisman M 2018 High serum thyrotropin concentrations within the reference range: A predictor of malignancy in nodular thyroid disease. Medical Principles & Practice 27 272277. (https://doi.org/10.1159/000488196)

    • Search Google Scholar
    • Export Citation
  • Dvorkin S, Robenshtok E, Hirsch D, Strenov Y, Shimon I & Benbassat CA 2013 Differentiated thyroid cancer is associated with less aggressive disease and better outcome in patients with coexisting Hashimotos thyroiditis. Journal of Clinical Endocrinology & Metabolism 98 24092414. (https://doi.org/10.1210/jc.2013-1309)

    • Search Google Scholar
    • Export Citation
  • Fiore E, Rago T, Provenzale MA, Scitari M, Uqolini C, Basolo F, Di Coscio G, Berti P, Grasso L & Elisei R et al. 2009 Lower levels of TSH are associated to a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocrine-Related Cancer 16 12511260. (https://doi.org/10.1677/ERC-09-0036)

    • Search Google Scholar
    • Export Citation
  • Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, Cerutti JM, Dinauer CA, Hamilton J, Hay ID & Luster M et al. 2015 Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid 25 716759. (https://doi.org/10.1089/thy.2014.0460)

    • Search Google Scholar
    • Export Citation
  • Franco AT, Malaguarnera R, Refetoff S, Liao XH, Lundsmith E, Kimura S, Pritchard C, Marais R, Davies TF & Weinstein LS et al. 2011 Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice. Proceedings of the National Academy of Sciences of the United States of America 108 16151620. (https://doi.org/10.1073/pnas.1015557108)

    • Search Google Scholar
    • Export Citation
  • Gharib H & Papini E 2007 Thyroid nodules: clinical importance, assessment, and treatment. Endocrinology & Metabolism Clinics of North America 36 70735, vi. (https://doi.org/10.1016/j.ecl.2007.04.009)

    • Search Google Scholar
    • Export Citation
  • Giagourta I, Evangelopoulou C, Papaioannou G, Kassi G, Zapanti E, Prokopiou M, Papapostolou K & Karga H 2014 Autoimmune thyroiditis in benign and malignant thyroid nodules: 16-year results. Head & Neck 36 531535. (https://doi.org/10.1002/hed.23331)

    • Search Google Scholar
    • Export Citation
  • Gupta A, Ly S, Castroneves LA, Frates MC, Benson CB, Feldman HA, Wassner AJ, Smith JR, Marqusee E & Alexander EK et al. 2013 A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults. Journal of Clinical Endocrinology & Metabolism 98 32383245. (https://doi.org/10.1210/jc.2013-1796)

    • Search Google Scholar
    • Export Citation
  • Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC & Chen H 2008 Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. Journal of Clinical Endocrinology & Metabolism 93 809814. (https://doi.org/10.1210/jc.2007-2215)

    • Search Google Scholar
    • Export Citation
  • Holm LE, Blomgren H & Löwhagen T 1985 Cancer risks in patients with chronic lymphocytic thyroiditis. New England Journal of Medicine 312 601604. (https://doi.org/10.1056/NEJM198503073121001)

    • Search Google Scholar
    • Export Citation
  • Ichikawa Y, Saito E, Abe Y, Homma M & Muraki T 1976 Presence of TSH receptor in thyroid neoplasms. Journal of Clinical Endocrinology & Metabolism 42 395398. (https://doi.org/10.1210/jcem-42-2-395)

    • Search Google Scholar
    • Export Citation
  • Imam S, Dar P, Paparodis R, Almotah K, Al-Khudhair A, Hasan SA, Salim N & Jaume JC 2019 Nature of coexisting thyroid autoimmune disease determines success or failure of tumor immunity in thyroid cancer. Journal for ImmunoTherapy of Cancer 7 3. (https://doi.org/10.1186/s40425-018-0483-y)

    • Search Google Scholar
    • Export Citation
  • Imam S, Paparodis R, Sharma D & Jaume JC 2014 Lymphocytic profiling in thyroid cancer provides clues for failure of tumor immunity. Endocrine-Related Cancer 21 505516. (https://doi.org/10.1530/ERC-13-0436)

    • Search Google Scholar
    • Export Citation
  • Jackson D, Handelsman RS, Farrá JC & Lew JI 2020 Increased incidental thyroid cancer in patients With subclinical chronic lymphocytic thyroiditis. Journal of Surgical Research 245 115118. (https://doi.org/10.1016/j.jss.2019.07.025)

    • Search Google Scholar
    • Export Citation
  • Kashima K, Yokoyama S, Noguchi S, Murakami N, Yamashita H, Watanabe S, Uchino S, Toda M, Sasaki A & Daa T et al. 1998 Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma. Thyroid 8 197202. (https://doi.org/10.1089/thy.1998.8.197)

    • Search Google Scholar
    • Export Citation
  • Keskin M, Savas-Erdeve S & Aycan Z 2016 Co-existence of thyroid nodule and thyroid cancer in children and adolescents with Hashimoto thyroiditis: a single-center study. Hormone Research in Paediatrics 85 181187. (https://doi.org/10.1159/000443143)

    • Search Google Scholar
    • Export Citation
  • Kim HK, Yoon JH, Kim SJ, Cho JS, Kweon SS & Kang HC 2013 Higher TSH level is a risk factor for differentiated thyroid cancer. Clinical Endocrinology 78 472477. (https://doi.org/10.1111/cen.12027)

    • Search Google Scholar
    • Export Citation
  • Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE & Roger PP 2001 Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocrine Reviews 22 631656. (https://doi.org/10.1210/edrv.22.5.0444)

    • Search Google Scholar
    • Export Citation
  • Klubo-Gwiezdzinska J, Auh S, Gershengorn M, Daley B, Bikas A, Burman K, Wartofsky L, Urken M, Dewey E & Smallridge R et al. 2019 Association of thyrotropin suppression With survival outcomes in patients With intermediate- and high-risk differentiated thyroid cancer. JAMA Network Open 2 e187754. (https://doi.org/10.1001/jamanetworkopen.2018.7754)

    • Search Google Scholar
    • Export Citation
  • Lu C, Zhao L, Ying H, Willingham MC & Cheng SY 2010 Growth activation alone is not sufficient to cause metastatic thyroid cancer in a mouse model of follicular thyroid carcinoma. Endocrinology 151 19291939. (https://doi.org/10.1210/en.2009-1017)

    • Search Google Scholar
    • Export Citation
  • Lun Y, Wu X, Xia Q, Han Y, Zhang X, Liu Z, Wang F, Duan Z, Xin S & Zhang J 2013 Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis. Otolaryngology--Head and Neck Surgery 148 396402. (https://doi.org/10.1177/0194599812472426)

    • Search Google Scholar
    • Export Citation
  • Moon SS, Lee YS, Lee IK & Kim JG 2012 Serum thyrotropin as a risk factor for thyroid malignancy in euthyroid subjects with thyroid micronodule. Head & Neck 34 949952. (https://doi.org/10.1002/hed.21828)

    • Search Google Scholar
    • Export Citation
  • Mussa A, Salerno MC, Bona G, Wasniewska M, Segni M, Cassio A, Vigone MC, Gastaldi R, Iughetti L & Santanera A et al. 2013 Serum thyrotropin concentration in children with isolated thyroid nodules. Journal of Pediatrics 163 14651470. (https://doi.org/10.1016/j.jpeds.2013.07.003)

    • Search Google Scholar
    • Export Citation
  • Orouji Jokar T, Fourman LT, Lee H, Mentzinger K & Fazeli PK 2018 Higher TSH levels Within the normal range are associated With unexplained infertility. Journal of Clinical Endocrinology & Metabolism 103 632639. (https://doi.org/10.1210/jc.2017-02120)

    • Search Google Scholar
    • Export Citation
  • Qin J, Yu Z, Guan H, Shi L, Liu Y, Zhao N, Shan Z, Han C, Li Y & Teng W 2015 High thyroglobulin antibody levels increase the risk of differentiated thyroid carcinoma. Disease Markers 2015 648670. (https://doi.org/10.1155/2015/648670)

    • Search Google Scholar
    • Export Citation
  • Ren PY, Liu J, Xue S & Chen G 2019 Paediatric differentiated thyroid carcinoma: the clinicopahological features and the coexistence of Hashimoto’s thyroiditis. Asian Journal of Surgery 42 112119. (https://doi.org/10.1016/j.asjsur.2017.10.006)

    • Search Google Scholar
    • Export Citation
  • Rinaldi S, Plummer M, Biessy C, Tsilidis KK, Østergaard JN, Overvad K, Tjønneland A, Halkjaer J, Boutron-Ruault MC & Clavel-Chapelon F et al. 2014 Thyroid-stimulating hormone, thyroglobulin, and thyroid hormones and risk of differentiated thyroid carcinoma: the EPIC study. Journal of the National Cancer Institute 106 dju097. (https://doi.org/10.1093/jnci/dju097)

    • Search Google Scholar
    • Export Citation
  • Shi RL, Liao T, Qu N, Liang F, Chen JY & Ji QH 2016 The usefulness of preoperative thyroid-stimulating hormone for predicting differentiated thyroid microcarcinoma. Otolaryngology: Head & Neck Surgery 154 256262. (https://doi.org/10.1177/0194599815618388)

    • Search Google Scholar
    • Export Citation
  • Siegel R, Ma J, Zou Z & Jemal A 2014 Cancer statistics, 2014. CA: A Cancer Journal for Clinicians 64 929. (https://doi.org/10.3322/caac.21208)

  • . Sugitani I & Fujimoto Y 2010 Does postoperative thyrotropin suppression therapy truly decrease recurrence in papillary thyroid carcinoma? A randomized controlled trial. Journal of Clinical Endocrinology & Metabolism 95 45764583. (https://doi.org/10.1210/jc.2010-0161)

    • Search Google Scholar
    • Export Citation
  • Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M & Dal Maso L 2016 Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. New England Journal of Medicine 375 614617. (https://doi.org/10.1056/NEJMp1604412)

    • Search Google Scholar
    • Export Citation
  • Vergamini LB, Frazier AL, Abrantes FL, Ribeiro KB & Rodriguez-Galindo C 2014 Increase in the incidence of differentiated thyroid carcinoma in children, adolescents, and young adults: a population-based study. Journal of Pediatrics 164 14811485. (https://doi.org/10.1016/j.jpeds.2014.01.059)

    • Search Google Scholar
    • Export Citation
  • Wang G, He L, Wang S, Zhang M, Li Y, Liu Q, Sun N, Zhang X, Liu Y & Zhang J et al. 2020 EV PD-L1 is correlated with clinical features and contributes to T cell suppression in pediatric thyroid cancer. Journal of Clinical Endocrinology & Metabolism 105 e2970e2981. (https://doi.org/10.1210/clinem/dgaa309)

    • Search Google Scholar
    • Export Citation
  • Wheeler E, Choy KW, Chin LK, Wijeratne N, McNeil A, Yen T, Matthews S, Deam D, Lu Z & Loh TP et al. 2019 Routine free thyroxine reference intervals are suboptimal for monitoring children on thyroxine replacement therapy and target intervals need to be assay-specific. Scientific Reports 9 19080. (https://doi.org/10.1038/s41598-019-55690-x)

    • Search Google Scholar
    • Export Citation
  • Zafon C, Obiols G & Mesa J 2015 Preoperative TSH level and risk of thyroid cancer in patients with nodular thyroid disease: nodule size contribution. Endocrinologia y Nutricion: Organo de la Sociedad Espanola de Endocrinologia y Nutricion 62 2428. (https://doi.org/10.1016/j.endonu.2014.06.002)

    • Search Google Scholar
    • Export Citation